ArticleCureus2024

Addition of Dulaglutide or Empagliflozin to Standard-of-Care Treatment: Effect on Liver Steatosis in Patients With Type 2 Diabetes Mellitus.

Emmanouil Koullias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.